British Association of Dermatologists’ guidelines for the management of pemphigus vulgaris 2017

Plain language summary available online

Saved in:

Bibliographic Details
Published in	British journal of dermatology (1951) Vol. 177; no. 5; pp. 1170 - 1201
Main Authors	Harman, K.E., Brown, D., Exton, L.S., Groves, R.W., Hampton, P.J., Mohd Mustapa, M.F., Setterfield, J.F., Yesudian, P.D.
Format	Journal Article
Language	English
Published	England Oxford University Press 01.11.2017
Subjects	Administration, Cutaneous Administration, Oral Adrenal Cortex Hormones - administration & dosage Aftercare Autoimmune diseases Blister - therapy Chemotherapy, Adjuvant Child Clinical Laboratory Techniques - methods Dermatologic Agents - therapeutic use Dose-Response Relationship, Drug Drug Therapy, Combination Female Forecasting Humans Immunosorbent Techniques Immunosuppressive Agents - therapeutic use Infusions, Intravenous Nursing Care Pemphigus Pemphigus - diagnosis Pemphigus - therapy Photopheresis - methods Plasma Exchange - methods Plasmapheresis - methods Pregnancy Pregnancy Complications - therapy Refusal to Treat Remission Induction Skin diseases Social Support
Online Access	Get full text
ISSN	0007-0963 1365-2133 1365-2133
DOI	10.1111/bjd.15930

Cover

More Information
Summary:	Plain language summary available online
Bibliography:	Funding sources Development of this guideline has been funded independently by the British Association of Dermatologists. BAD Scientific Administrator), L.S. Exton Produced in 2003 by the British Association of Dermatologists; reviewed and updated 2017. . Clinical Standards Manager). NICE has accredited the process used by the British Association of Dermatologists to produce guidelines. The renewed accreditation is valid until 31 May 2021 and applies to guidance produced using the process described in updated guidance for writing a British Association of Dermatologists clinical guidance – the adoption of the GRADE methodology 2016. The original accreditation term began on 12 May 2010. More information on accreditation can be viewed at Clinical Standards Unit, which includes the Therapy & Guidelines (T&G) Subcommittee. Members of the Clinical Standards Unit who have been involved are P.M. McHenry (Chair T&G), K. Gibbon, D.A. Buckley, T.A. Leslie, E.C. Mallon, S. Wakelin, S. Ungureanu, R.Y.P. Hunasehally, M. Cork, G.A. Johnston, J. Natkunarajah, F.S. Worsnop, N. Chiang, C.E. Duarte Williamson, J. Donnelly (British National Formulary), C. Saunders (British Dermatological Nursing Group), A.G. Brain www.nice.org.uk/accreditation K.E.H., D.B., R.W.G., P.J.H., J.F.S. and P.D.Y. are members of the guideline development group, with technical support provided by L.S.E. and M.F.M.M. Conflicts of interest Information Scientist) and M.F. Mohd Mustapa This is an updated guideline prepared for the British Association of Dermatologists None declared. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Instructional Material/Guideline-3 content type line 23
ISSN:	0007-0963 1365-2133 1365-2133
DOI:	10.1111/bjd.15930